Global Single Cell Multiomics Market Outlook, 2030
The global single-cell multiomics market will reach $14.37B, driven by demand for precision medicine and biotech research.
- Bonafide Trust
- 21-03-2025
- Pages : 207
- Region : Global
- Category : Lifescience
- Biotechnology
Imagine a world where we can eavesdrop on the intricate conversations happening within each individual cell, deciphering their unique language and understanding their specific roles in the grand symphony of life. This is the captivating promise of single cell multiomics, a groundbreaking field that delves into the complexities of individual cells by analyzing multiple "omics" layers simultaneously. This includes genomics, the study of DNA; transcriptomics, the study of RNA; proteomics, the study of proteins; and epigenomics, the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. By providing a comprehensive and integrated view of cellular heterogeneity and function, this technology is revolutionizing our understanding of complex biological processes, disease mechanisms, and drug responses. Think of it like this: instead of observing a crowd of people from a distance, single cell multiomics allows us to zoom in on each individual, understanding their unique characteristics, behaviors, and interactions. This granular level of detail is transforming our approach to healthcare. The increasing prevalence of chronic diseases like cancer, diabetes, and autoimmune disorders, coupled with an aging population, is driving the demand for early diagnostics, targeted therapies, and personalized medicine. Single cell multiomics offers the potential to identify disease biomarkers, predict disease progression, and develop more effective treatments tailored to individual patients, further propelling the market's growth.
Global single cell multiomics market will reach $14,369.5 million by 2031, growing by 18.6% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication. The single cell multiomics market is experiencing a dynamic transformation, characterized by a paradigm shift towards cloud-based platforms for data analysis and storage. This transition is fostering a new era of global collaboration and data sharing among researchers, breaking down traditional barriers and accelerating scientific discovery. Imagine a global network of scientists working together seamlessly, sharing data and insights in real-time to unravel the mysteries of cellular function. This is the power of cloud-based platforms in single cell multiomics. This technological leap is fueled by a confluence of factors, including continuous innovation, substantial R&D investments, and a growing emphasis on precision medicine. Advancements in microfluidics, high-throughput sequencing, and bioinformatics are enabling researchers to generate and analyze vast amounts of single-cell data with unprecedented speed and accuracy. Recognizing the transformative potential of single cell multiomics, governments worldwide are implementing initiatives and trade programs to support research and development in life sciences. These programs provide funding opportunities, encourage collaborations between academia and industry, and foster a conducive environment for innovation, further accelerating market growth.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleThe single cell multiomics market offers a diverse and constantly evolving toolkit, categorized into consumables and instruments. Consumables, which include reagents, kits, and other disposable materials, currently dominate the market due to their recurring demand and the increasing number of research projects utilizing single cell multiomics technologies. These essential components are the fuel that drives the single cell multiomics engine, enabling researchers to isolate, prepare, and analyze individual cells. Instruments, on the other hand, represent the sophisticated machinery that powers the single cell multiomics workflow. This category includes a wide range of technologies, such as flow cytometers, microfluidic devices, and high-throughput sequencers. These instruments are constantly evolving, with ongoing innovations in microfluidics and high-throughput technologies driving this segment's growth. For instance, advancements in microfluidics are enabling researchers to manipulate and analyze single cells with greater precision and efficiency, while high-throughput sequencers are generating vast amounts of data at an unprecedented rate.
Single cell multiomics is like listening to a complex symphony orchestra, where each instrument represents a different "omics" layer, and each musician is a single cell. By listening to the individual instruments and how they interact, we can gain a deeper appreciation for the overall composition. Single cell multiomics encompasses various omics layers, including genomics, transcriptomics, proteomics, epigenomics, and others. Each layer provides a unique perspective on cellular function, and by integrating these layers, we can gain a more holistic understanding of the cellular symphony. Transcriptomics, which focuses on the study of RNA molecules and gene expression patterns, currently leads the market. It provides crucial insights into the dynamic processes of gene regulation and protein synthesis within individual cells. However, the integration of multiple omics layers is gaining momentum, enabling a more comprehensive and nuanced understanding of cellular processes. For instance, combining transcriptomics with proteomics can reveal how gene expression translates into protein function, while integrating genomics can provide insights into the underlying genetic variations that influence cellular behavior.
Single cell multiomics is like a powerful spotlight, illuminating diverse fields of biological research and revealing hidden details that were previously obscured. It is finding applications in a wide range of areas, including oncology, immunology, neurology, and stem cell research, driving advancements in disease understanding, diagnosis, and treatment. Oncology, the study of cancer, currently holds the largest market share due to the rising cancer prevalence and the technology's potential for early cancer detection, personalized treatment selection, and monitoring therapeutic responses. By analyzing the heterogeneity of cancer cells, single cell multiomics can help identify rare cancer stem cells, predict drug resistance, and guide the development of more effective targeted therapies. In immunology, single cell multiomics is providing insights into the complex interplay of immune cells, leading to a better understanding of immune responses and the development of novel immunotherapies. In neurology, it is being used to study the diversity of brain cells and their roles in neurological disorders, paving the way for new diagnostic tools and treatments for diseases like Alzheimer's and Parkinson's.
The single cell multiomics market caters to a variety of sample types, including cell lines, tissues, and other biological materials. Cell lines, which are populations of cells derived from a single source and grown in laboratory conditions, are widely used due to their ease of handling, availability, and reproducibility. They provide a valuable model system for studying cellular processes and testing new drugs and therapies. However, the use of tissue samples is increasing as it provides a more accurate representation of the cellular complexity within an organism. Tissues are composed of diverse cell types organized in a specific architecture, and analyzing them at the single-cell level can reveal how different cells interact and contribute to tissue function. This is particularly important for understanding diseases that affect specific tissues or organs, such as cancer, heart disease, and kidney disease.
The single cell multiomics workflow is like a carefully choreographed dance, involving several key steps that must be executed with precision and care. It begins with single cell isolation, where individual cells are carefully separated from a complex mixture, like a blood sample or a tissue biopsy. This step is crucial for ensuring the accuracy and reliability of downstream analyses. Next comes library preparation, where the genetic material (DNA or RNA) from each cell is extracted, amplified, and converted into a format suitable for sequencing. This step involves a series of biochemical reactions that must be carefully optimized to preserve the integrity of the genetic material and minimize bias. Sequencing is the process of reading the genetic code of each cell, generating vast amounts of data that must be carefully analyzed to extract meaningful insights. Finally, data analysis involves using sophisticated bioinformatics tools to process, interpret, and visualize the sequencing data, identifying patterns, trends, and relationships that can shed light on cellular function and disease mechanisms.
The single cell multiomics market is driven by a diverse community of end users, including academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and diagnostic laboratories. Academic and research institutes currently dominate the market, driven by their insatiable curiosity to explore the uncharted territories of cellular biology and unravel the mysteries of life. They are at the forefront of single cell multiomics research, pushing the boundaries of knowledge and developing new technologies and applications. However, the increasing adoption of single cell multiomics in drug discovery and diagnostics is fueling the growth of the pharmaceutical and biotechnology segments. Pharmaceutical companies are using single cell multiomics to identify new drug targets, develop more effective therapies, and personalize treatment strategies. Biotechnology companies are developing innovative tools and technologies to support single cell multiomics research, such as microfluidic devices, high-throughput sequencers, and bioinformatics software. Hospitals and diagnostic laboratories are beginning to adopt single cell multiomics for clinical applications, such as cancer diagnosis, infectious disease monitoring, and organ transplantation.
The single cell multiomics market is a global phenomenon, with research and development activities taking place in various regions around the world. North America currently leads the market due to the presence of key players, advanced research infrastructure, and substantial investments in life sciences research. The United States, in particular, is a major hub for single cell multiomics research, with numerous academic institutions, biotechnology companies, and pharmaceutical giants driving innovation in the field. The Asia-Pacific region is poised for rapid growth, driven by increasing government support for research, rising healthcare expenditure, and a growing focus on precision medicine. Countries like China, Japan, and South Korea are making significant investments in life sciences research and development, and their rapidly growing economies are creating a favorable environment for the adoption of new technologies like single cell multiomics. Europe is another significant market with a strong emphasis on research and development in life sciences. European countries have a long tradition of excellence in scientific research, and they are home to many world-renowned universities and research institutions that are actively involved in single cell multiomics research.
Table of Contents
- 1 Introduction 11
- 1.1 Industry Definition and Research Scope 11
- 1.1.1 Industry Definition 11
- 1.1.2 Research Scope 12
- 1.2 Research Methodology 15
- 1.2.1 Overview of Market Research Methodology 15
- 1.2.2 Market Assumption 16
- 1.2.3 Secondary Data 16
- 1.2.4 Primary Data 16
- 1.2.5 Data Filtration and Model Design 17
- 1.2.6 Market Size/Share Estimation 18
- 1.2.7 Research Limitations 19
- 1.3 Executive Summary 20
- 2 Market Overview and Dynamics 23
- 2.1 Market Size and Forecast 23
- 2.1.1 Impact of COVID-19 on World Economy 24
- 2.1.2 Impact of COVID-19 on the Market 28
- 2.2 Major Growth Drivers 30
- 2.3 Market Restraints and Challenges 38
- 2.4 Emerging Opportunities and Market Trends 41
- 2.5 Porter’s Fiver Forces Analysis 45
- 3 Segmentation of Global Market by Product Type 49
- 3.1 Market Overview by Product Type 49
- 3.2 Instruments 51
- 3.3 Consumables 52
- 3.4 Software 53
- 4 Segmentation of Global Market by Omics Type 54
- 4.1 Market Overview by Omics Type 54
- 4.2 Single Cell Genomics (SCG) 56
- 4.3 Single Cell Transcriptomics (SCT) 57
- 4.4 Single Cell Proteomics (SCP) 58
- 4.5 Single Cell Metabolomics (SCM) 59
- 5 Segmentation of Global Market by Application 60
- 5.1 Market Overview by Application 60
- 5.2 Clinical Research 62
- 5.2.1 Oncology 64
- 5.2.2 Cell Therapy 65
- 5.2.3 Immunology 66
- 5.2.4 Neurology 67
- 5.2.5 Cell Biology 68
- 5.2.6 Other Types of Clinical Research 69
- 5.3 Translation Research 70
- 5.4 Synthetic Biology 71
- 6 Segmentation of Global Market by Sample Type 72
- 6.1 Market Overview by Sample Type 72
- 6.2 Human Samples 74
- 6.2.1 Cancer Tissues 76
- 6.2.2 Stem Cells 77
- 6.2.3 Immune Cells 78
- 6.2.4 Brain Cells 79
- 6.2.5 Other Human Samples 80
- 6.3 Animal Samples 81
- 6.4 Microbial Samples 82
- 7 Segmentation of Global Market by Workflow 83
- 7.1 Market Overview by Workflow 83
- 7.2 Single-Cell Isolation and Dispensing 85
- 7.2.1 Fluorescence-Activated Cell Sorting (FACS) 87
- 7.2.2 Microfluidics 88
- 7.2.3 Magnetic-Activated Cell Sorting (MACS) 89
- 7.2.4 Random Seeding 90
- 7.2.5 Manual Cell Picking 91
- 7.2.6 Laser Capture Microdissection 92
- 7.2.7 Other Technologies of Single-Cell Isolation and Dispensing 93
- 7.3 Single-Cell Analysis 94
- 7.3.1 Polymerase Chain Reaction 96
- 7.3.2 Next-Generation Sequencing 97
- 7.3.3 Mass Cytometry 98
- 7.3.4 Mass Spectrometry 99
- 7.3.5 Other Technologies of Single-Cell Analysis 100
- 8 Segmentation of Global Market by End User 101
- 8.1 Market Overview by End User 101
- 8.2 Research and Academic Laboratories 103
- 8.3 Biopharmaceutical and Biotech Companies 104
- 8.4 Contract Research Organizations (CROs) 105
- 8.5 Other End Users 106
- 9 Segmentation of Global Market by Region 107
- 9.1 Geographic Market Overview 2021-2031 107
- 9.2 North America Market 2021-2031 by Country 111
- 9.2.1 Overview of North America Market 111
- 9.2.2 U.S. 115
- 9.2.3 Canada 118
- 9.2.4 Mexico 120
- 9.3 European Market 2021-2031 by Country 122
- 9.3.1 Overview of European Market 122
- 9.3.2 Germany 126
- 9.3.3 U.K. 128
- 9.3.4 France 130
- 9.3.5 Spain 132
- 9.3.6 Italy 134
- 9.3.7 Netherlands 136
- 9.3.8 Rest of European Market 138
- 9.4 Asia-Pacific Market 2021-2031 by Country 140
- 9.4.1 Overview of Asia-Pacific Market 140
- 9.4.2 Japan 144
- 9.4.3 China 147
- 9.4.4 Australia 149
- 9.4.5 India 151
- 9.4.6 South Korea 153
- 9.4.7 Rest of APAC Region 155
- 9.5 South America Market 2021-2031 by Country 157
- 9.5.1 Argentina 160
- 9.5.2 Brazil 162
- 9.5.3 Chile 164
- 9.5.4 Rest of South America Market 166
- 9.6 MEA Market 2021-2031 by Country 167
- 9.6.1 UAE 170
- 9.6.2 Saudi Arabia 172
- 9.6.3 South Africa 174
- 9.6.4 Other National Markets 176
- 10 Competitive Landscape 177
- 10.1 Overview of Key Vendors 177
- 10.2 New Product Launch, Partnership, Investment, and M&A 181
- 10.3 Company Profiles 182
- 10x Genomics, Inc. 182
- 1CellBio, Inc. 184
- Becton, Dickinson and Company 185
- Berkeley Lights, Inc. 186
- BGI Genomics Co., Ltd. 187
- Bio-Rad Laboratories, Inc. 188
- Bio-Techne Corporation 189
- BioTuring, Inc. 190
- Danaher Corporation (Cytiva Life Sciences) 191
- Dolomite Bio 192
- Fluidigm Corporation 193
- Fluxion Biosciences 194
- Illimina, Inc 195
- Mission Bio, Inc. 196
- Namocell, Inc. 197
- NanoString Technologies, Inc. 198
- Parse Biosciences, Inc. 199
- Proteona 200
- Qiagen N.V. 201
- RareCyte, Inc. 202
- Scipio Biosciences SAS 203
- Shilps Sciences 204
- Takara Bio Inc. (Takara Holdings) 205
- Thermo Fisher Scientific Inc. 206
- RELATED REPORTS 207
List of Tables:
Table 1. Snapshot of Global Single Cell Multiomics Market in Balanced Perspective, 2021-2031 21
Table 2. World Economic Outlook, 2021-2031 25
Table 3. World Economic Outlook, 2021-2023 26
Table 4. Comparison of Rare Disease in Different Countries 35
Table 5. World Health Spending by Region, $ bn, 2013-2020 37
Table 6. Main Product Trends and Market Opportunities in Global Single Cell Multiomics Market 41
Table 7. Global Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 49
Table 8. Global Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 54
Table 9. Global Single Cell Multiomics Market by Application, 2021-2031, $ mn 60
Table 10. Global Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 63
Table 11. Global Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 72
Table 12. Global Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 75
Table 13. Global Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 83
Table 14. Global Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 86
Table 15. Global Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 95
Table 16. Global Single Cell Multiomics Market by End User, 2021-2031, $ mn 101
Table 17. Global Single Cell Multiomics Market by Region, 2021-2031, $ mn 108
Table 18. Leading National Single Cell Multiomics Market, 2021 and 2031, $ mn 110
Table 19. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn 113
Table 20. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 117
Table 21. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 117
Table 22. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn 117
Table 23. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 119
Table 24. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 119
Table 25. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn 119
Table 26. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 121
Table 27. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 121
Table 28. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn 121
Table 29. Europe Single Cell Multiomics Market by Country, 2021-2031, $ mn 125
Table 30. Germany Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 127
Table 31. Germany Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 127
Table 32. Germany Single Cell Multiomics Market by End User, 2021-2031, $ mn 127
Table 33. U.K. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 129
Table 34. U.K. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 129
Table 35. U.K. Single Cell Multiomics Market by End User, 2021-2031, $ mn 129
Table 36. France Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 131
Table 37. France Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 131
Table 38. France Single Cell Multiomics Market by End User, 2021-2031, $ mn 131
Table 39. Spain Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 133
Table 40. Spain Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 133
Table 41. Spain Single Cell Multiomics Market by End User, 2021-2031, $ mn 133
Table 42. Italy Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 135
Table 43. Italy Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 135
Table 44. Italy Single Cell Multiomics Market by End User, 2021-2031, $ mn 135
Table 45. Netherlands Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 137
Table 46. Netherlands Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 137
Table 47. Netherlands Single Cell Multiomics Market by End User, 2021-2031, $ mn 137
Table 48. Single Cell Multiomics Market in Rest of Europe by Country, 2021-2031, $ mn 139
Table 49. APAC Single Cell Multiomics Market by Country, 2021-2031, $ mn 142
Table 50. Japan Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 146
Table 51. Japan Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 146
Table 52. Japan Single Cell Multiomics Market by End User, 2021-2031, $ mn 146
Table 53. China Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 148
Table 54. China Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 148
Table 55. China Single Cell Multiomics Market by End User, 2021-2031, $ mn 148
Table 56. Australia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 150
Table 57. Australia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 150
Table 58. Australia Single Cell Multiomics Market by End User, 2021-2031, $ mn 150
Table 59. India Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 152
Table 60. India Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 152
Table 61. India Single Cell Multiomics Market by End User, 2021-2031, $ mn 152
Table 62. South Korea Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 154
Table 63. South Korea Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 154
Table 64. South Korea Single Cell Multiomics Market by End User, 2021-2031, $ mn 154
Table 65. Single Cell Multiomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 156
Table 66. South America Single Cell Multiomics Market by Country, 2021-2031, $ mn 159
Table 67. Argentina Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 161
Table 68. Argentina Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 161
Table 69. Argentina Single Cell Multiomics Market by End User, 2021-2031, $ mn 161
Table 70. Brazil Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 163
Table 71. Brazil Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 163
Table 72. Brazil Single Cell Multiomics Market by End User, 2021-2031, $ mn 163
Table 73. Chile Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 165
Table 74. Chile Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 165
Table 75. Chile Single Cell Multiomics Market by End User, 2021-2031, $ mn 165
Table 76. MEA Single Cell Multiomics Market by Country, 2021-2031, $ mn 169
Table 77. UAE Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 171
Table 78. UAE Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 171
Table 79. UAE Single Cell Multiomics Market by End User, 2021-2031, $ mn 171
Table 80. Saudi Arabia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 173
Table 81. Saudi Arabia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 173
Table 82. Saudi Arabia Single Cell Multiomics Market by End User, 2021-2031, $ mn 173
Table 83. South Africa Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 175
Table 84. South Africa Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 175
Table 85. South Africa Single Cell Multiomics Market by End User, 2021-2031, $ mn 175
Table 86. Breakdown of World Market by Key Vendor, 2020, % 179
Table 87. 10x Genomics, Inc.: Company Snapshot 182
Table 88. 10x Genomics, Inc.: Business Segmentation 183
Table 89. 10x Genomics, Inc.: Product Portfolio 183
Table 1. Snapshot of Global Single Cell Multiomics Market in Balanced Perspective, 2021-2031 21
Table 2. World Economic Outlook, 2021-2031 25
Table 3. World Economic Outlook, 2021-2023 26
Table 4. Comparison of Rare Disease in Different Countries 35
Table 5. World Health Spending by Region, $ bn, 2013-2020 37
Table 6. Main Product Trends and Market Opportunities in Global Single Cell Multiomics Market 41
Table 7. Global Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 49
Table 8. Global Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 54
Table 9. Global Single Cell Multiomics Market by Application, 2021-2031, $ mn 60
Table 10. Global Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 63
Table 11. Global Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 72
Table 12. Global Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 75
Table 13. Global Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 83
Table 14. Global Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 86
Table 15. Global Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 95
Table 16. Global Single Cell Multiomics Market by End User, 2021-2031, $ mn 101
Table 17. Global Single Cell Multiomics Market by Region, 2021-2031, $ mn 108
Table 18. Leading National Single Cell Multiomics Market, 2021 and 2031, $ mn 110
Table 19. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn 113
Table 20. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 117
Table 21. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 117
Table 22. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn 117
Table 23. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 119
Table 24. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 119
Table 25. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn 119
Table 26. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 121
Table 27. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 121
Table 28. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn 121
Table 29. Europe Single Cell Multiomics Market by Country, 2021-2031, $ mn 125
Table 30. Germany Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 127
Table 31. Germany Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 127
Table 32. Germany Single Cell Multiomics Market by End User, 2021-2031, $ mn 127
Table 33. U.K. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 129
Table 34. U.K. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 129
Table 35. U.K. Single Cell Multiomics Market by End User, 2021-2031, $ mn 129
Table 36. France Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 131
Table 37. France Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 131
Table 38. France Single Cell Multiomics Market by End User, 2021-2031, $ mn 131
Table 39. Spain Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 133
Table 40. Spain Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 133
Table 41. Spain Single Cell Multiomics Market by End User, 2021-2031, $ mn 133
Table 42. Italy Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 135
Table 43. Italy Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 135
Table 44. Italy Single Cell Multiomics Market by End User, 2021-2031, $ mn 135
Table 45. Netherlands Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 137
Table 46. Netherlands Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 137
Table 47. Netherlands Single Cell Multiomics Market by End User, 2021-2031, $ mn 137
Table 48. Single Cell Multiomics Market in Rest of Europe by Country, 2021-2031, $ mn 139
Table 49. APAC Single Cell Multiomics Market by Country, 2021-2031, $ mn 142
Table 50. Japan Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 146
Table 51. Japan Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 146
Table 52. Japan Single Cell Multiomics Market by End User, 2021-2031, $ mn 146
Table 53. China Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 148
Table 54. China Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 148
Table 55. China Single Cell Multiomics Market by End User, 2021-2031, $ mn 148
Table 56. Australia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 150
Table 57. Australia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 150
Table 58. Australia Single Cell Multiomics Market by End User, 2021-2031, $ mn 150
Table 59. India Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 152
Table 60. India Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 152
Table 61. India Single Cell Multiomics Market by End User, 2021-2031, $ mn 152
Table 62. South Korea Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 154
Table 63. South Korea Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 154
Table 64. South Korea Single Cell Multiomics Market by End User, 2021-2031, $ mn 154
Table 65. Single Cell Multiomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 156
Table 66. South America Single Cell Multiomics Market by Country, 2021-2031, $ mn 159
Table 67. Argentina Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 161
Table 68. Argentina Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 161
Table 69. Argentina Single Cell Multiomics Market by End User, 2021-2031, $ mn 161
Table 70. Brazil Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 163
Table 71. Brazil Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 163
Table 72. Brazil Single Cell Multiomics Market by End User, 2021-2031, $ mn 163
Table 73. Chile Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 165
Table 74. Chile Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 165
Table 75. Chile Single Cell Multiomics Market by End User, 2021-2031, $ mn 165
Table 76. MEA Single Cell Multiomics Market by Country, 2021-2031, $ mn 169
Table 77. UAE Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 171
Table 78. UAE Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 171
Table 79. UAE Single Cell Multiomics Market by End User, 2021-2031, $ mn 171
Table 80. Saudi Arabia Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 173
Table 81. Saudi Arabia Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 173
Table 82. Saudi Arabia Single Cell Multiomics Market by End User, 2021-2031, $ mn 173
Table 83. South Africa Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 175
Table 84. South Africa Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 175
Table 85. South Africa Single Cell Multiomics Market by End User, 2021-2031, $ mn 175
Table 86. Breakdown of World Market by Key Vendor, 2020, % 179
Table 87. 10x Genomics, Inc.: Company Snapshot 182
Table 88. 10x Genomics, Inc.: Business Segmentation 183
Table 89. 10x Genomics, Inc.: Product Portfolio 183
List of Figures:
Figure 1. Research Method Flow Chart 15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20
Figure 4. Global Single Cell Multiomics Market, 2021-2031, $ mn 23
Figure 5. Impact of COVID-19 on Business 28
Figure 6. Primary Drivers and Impact Factors of Global Single Cell Multiomics Market 30
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 33
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019 34
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 36
Figure 11. Primary Restraints and Impact Factors of Global Single Cell Multiomics Market 38
Figure 12. Investment Opportunity Analysis 42
Figure 13. Porter’s Fiver Forces Analysis of Global Single Cell Multiomics Market 45
Figure 14. Breakdown of Global Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue 50
Figure 15. Global Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 50
Figure 16. Global Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn 51
Figure 17. Global Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn 52
Figure 18. Global Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn 53
Figure 19. Breakdown of Global Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue 55
Figure 20. Global Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%) 55
Figure 21. Global Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn 56
Figure 22. Global Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn 57
Figure 23. Global Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn 58
Figure 24. Global Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn 59
Figure 25. Breakdown of Global Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue 61
Figure 26. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 61
Figure 27. Global Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn 62
Figure 28. Global Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn 64
Figure 29. Global Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn 65
Figure 30. Global Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn 66
Figure 31. Global Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn 67
Figure 32. Global Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn 68
Figure 33. Global Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn 69
Figure 34. Global Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn 70
Figure 35. Global Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn 71
Figure 36. Breakdown of Global Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue 73
Figure 37. Global Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 73
Figure 38. Global Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn 74
Figure 39. Global Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn 76
Figure 40. Global Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn 77
Figure 41. Global Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn 78
Figure 42. Global Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn 79
Figure 43. Global Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn 80
Figure 44. Global Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn 81
Figure 45. Global Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn 82
Figure 46. Breakdown of Global Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue 84
Figure 47. Global Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%) 84
Figure 48. Global Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn 85
Figure 49. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn 87
Figure 50. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn 88
Figure 51. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn 89
Figure 52. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn 90
Figure 53. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn 91
Figure 54. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn 92
Figure 55. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn 93
Figure 56. Global Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn 94
Figure 57. Global Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn 96
Figure 58. Global Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn 97
Figure 59. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn 98
Figure 60. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn 99
Figure 61. Global Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn 100
Figure 62. Breakdown of Global Single Cell Multiomics Market by End User, 2021-2031, % of Revenue 101
Figure 63. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 102
Figure 64. Global Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn 103
Figure 65. Global Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn 104
Figure 66. Global Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 105
Figure 67. Global Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn 106
Figure 68. Global Market Snapshot by Region 107
Figure 69. Geographic Spread of Worldwide Single Cell Multiomics Market, 2021-2031, % of Sales Revenue 108
Figure 70. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 109
Figure 71. North American Single Cell Multiomics Market, 2021-2031, $ mn 112
Figure 72. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 113
Figure 73. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 114
Figure 74. U.S. Single Cell Multiomics Market, 2021-2031, $ mn 116
Figure 75. Canada Single Cell Multiomics Market, 2021-2031, $ mn 118
Figure 76. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn 120
Figure 77. European Single Cell Multiomics Market, 2021-2031, $ mn 123
Figure 78. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 124
Figure 79. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 125
Figure 80. Single Cell Multiomics Market in Germany, 2021-2031, $ mn 126
Figure 81. Single Cell Multiomics Market in U.K., 2021-2031, $ mn 128
Figure 82. Single Cell Multiomics Market in France, 2021-2031, $ mn 130
Figure 83. Single Cell Multiomics Market in Spain, 2021-2031, $ mn 132
Figure 84. Single Cell Multiomics Market in Italy, 2021-2031, $ mn 134
Figure 85. Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn 136
Figure 86. Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn 138
Figure 87. Asia-Pacific Single Cell Multiomics Market, 2021-2031, $ mn 141
Figure 88. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 141
Figure 89. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 143
Figure 90. Single Cell Multiomics Market in Japan, 2021-2031, $ mn 145
Figure 91. Single Cell Multiomics Market in China, 2021-2031, $ mn 147
Figure 92. Single Cell Multiomics Market in Australia, 2021-2031, $ mn 149
Figure 93. Single Cell Multiomics Market in India, 2021-2031, $ mn 151
Figure 94. Single Cell Multiomics Market in South Korea, 2021-2031, $ mn 153
Figure 95. Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn 155
Figure 96. South America Single Cell Multiomics Market, 2021-2031, $ mn 158
Figure 97. Breakdown of South America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 158
Figure 98. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 159
Figure 99. Single Cell Multiomics Market in Argentina, 2021-2031, $ mn 160
Figure 100. Single Cell Multiomics Market in Brazil, 2021-2031, $ mn 162
Figure 101. Single Cell Multiomics Market in Chile, 2021-2031, $ mn 164
Figure 102. Single Cell Multiomics Market in Rest of South America, 2021-2031, $ mn 166
Figure 103. Single Cell Multiomics Market in Middle East and Africa (MEA), 2021-2031, $ mn 168
Figure 104. Breakdown of MEA Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 168
Figure 105. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 169
Figure 106. Single Cell Multiomics Market in UAE, 2021-2031, $ mn 170
Figure 107. Single Cell Multiomics Market in Saudi Arabia, 2021-2031, $ mn 172
Figure 108. Single Cell Multiomics Market in South Africa, 2021-2031, $ mn 174
Figure 109. Growth Stage of Global Single Cell Multiomics Industry over the Forecast Period 177
Figure 1. Research Method Flow Chart 15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20
Figure 4. Global Single Cell Multiomics Market, 2021-2031, $ mn 23
Figure 5. Impact of COVID-19 on Business 28
Figure 6. Primary Drivers and Impact Factors of Global Single Cell Multiomics Market 30
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 33
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019 34
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 36
Figure 11. Primary Restraints and Impact Factors of Global Single Cell Multiomics Market 38
Figure 12. Investment Opportunity Analysis 42
Figure 13. Porter’s Fiver Forces Analysis of Global Single Cell Multiomics Market 45
Figure 14. Breakdown of Global Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue 50
Figure 15. Global Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 50
Figure 16. Global Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn 51
Figure 17. Global Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn 52
Figure 18. Global Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn 53
Figure 19. Breakdown of Global Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue 55
Figure 20. Global Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%) 55
Figure 21. Global Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn 56
Figure 22. Global Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn 57
Figure 23. Global Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn 58
Figure 24. Global Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn 59
Figure 25. Breakdown of Global Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue 61
Figure 26. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 61
Figure 27. Global Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn 62
Figure 28. Global Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn 64
Figure 29. Global Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn 65
Figure 30. Global Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn 66
Figure 31. Global Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn 67
Figure 32. Global Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn 68
Figure 33. Global Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn 69
Figure 34. Global Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn 70
Figure 35. Global Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn 71
Figure 36. Breakdown of Global Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue 73
Figure 37. Global Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 73
Figure 38. Global Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn 74
Figure 39. Global Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn 76
Figure 40. Global Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn 77
Figure 41. Global Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn 78
Figure 42. Global Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn 79
Figure 43. Global Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn 80
Figure 44. Global Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn 81
Figure 45. Global Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn 82
Figure 46. Breakdown of Global Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue 84
Figure 47. Global Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%) 84
Figure 48. Global Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn 85
Figure 49. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn 87
Figure 50. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn 88
Figure 51. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn 89
Figure 52. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn 90
Figure 53. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn 91
Figure 54. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn 92
Figure 55. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn 93
Figure 56. Global Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn 94
Figure 57. Global Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn 96
Figure 58. Global Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn 97
Figure 59. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn 98
Figure 60. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn 99
Figure 61. Global Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn 100
Figure 62. Breakdown of Global Single Cell Multiomics Market by End User, 2021-2031, % of Revenue 101
Figure 63. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 102
Figure 64. Global Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn 103
Figure 65. Global Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn 104
Figure 66. Global Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 105
Figure 67. Global Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn 106
Figure 68. Global Market Snapshot by Region 107
Figure 69. Geographic Spread of Worldwide Single Cell Multiomics Market, 2021-2031, % of Sales Revenue 108
Figure 70. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 109
Figure 71. North American Single Cell Multiomics Market, 2021-2031, $ mn 112
Figure 72. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 113
Figure 73. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 114
Figure 74. U.S. Single Cell Multiomics Market, 2021-2031, $ mn 116
Figure 75. Canada Single Cell Multiomics Market, 2021-2031, $ mn 118
Figure 76. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn 120
Figure 77. European Single Cell Multiomics Market, 2021-2031, $ mn 123
Figure 78. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 124
Figure 79. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 125
Figure 80. Single Cell Multiomics Market in Germany, 2021-2031, $ mn 126
Figure 81. Single Cell Multiomics Market in U.K., 2021-2031, $ mn 128
Figure 82. Single Cell Multiomics Market in France, 2021-2031, $ mn 130
Figure 83. Single Cell Multiomics Market in Spain, 2021-2031, $ mn 132
Figure 84. Single Cell Multiomics Market in Italy, 2021-2031, $ mn 134
Figure 85. Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn 136
Figure 86. Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn 138
Figure 87. Asia-Pacific Single Cell Multiomics Market, 2021-2031, $ mn 141
Figure 88. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 141
Figure 89. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 143
Figure 90. Single Cell Multiomics Market in Japan, 2021-2031, $ mn 145
Figure 91. Single Cell Multiomics Market in China, 2021-2031, $ mn 147
Figure 92. Single Cell Multiomics Market in Australia, 2021-2031, $ mn 149
Figure 93. Single Cell Multiomics Market in India, 2021-2031, $ mn 151
Figure 94. Single Cell Multiomics Market in South Korea, 2021-2031, $ mn 153
Figure 95. Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn 155
Figure 96. South America Single Cell Multiomics Market, 2021-2031, $ mn 158
Figure 97. Breakdown of South America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 158
Figure 98. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 159
Figure 99. Single Cell Multiomics Market in Argentina, 2021-2031, $ mn 160
Figure 100. Single Cell Multiomics Market in Brazil, 2021-2031, $ mn 162
Figure 101. Single Cell Multiomics Market in Chile, 2021-2031, $ mn 164
Figure 102. Single Cell Multiomics Market in Rest of South America, 2021-2031, $ mn 166
Figure 103. Single Cell Multiomics Market in Middle East and Africa (MEA), 2021-2031, $ mn 168
Figure 104. Breakdown of MEA Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 168
Figure 105. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 169
Figure 106. Single Cell Multiomics Market in UAE, 2021-2031, $ mn 170
Figure 107. Single Cell Multiomics Market in Saudi Arabia, 2021-2031, $ mn 172
Figure 108. Single Cell Multiomics Market in South Africa, 2021-2031, $ mn 174
Figure 109. Growth Stage of Global Single Cell Multiomics Industry over the Forecast Period 177
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization.png "Nikita Jabrela")
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (24 April, 2025)
- Notify To Team (24 April, 2025)
- Report updation (25 April, 2025)
- Report Quality Check (25 April, 2025)
- Report Dispatch (26 April, 2025)
- Hard Copy
Recently Viewed Products
Global Single Cell Multiomics Market Outlook, 2030
We are friendly and approachable, give us a call.